Back

Should dual antiplatelet therapy be maintained beyond one year after a myocardial infarction? A cohort study within the French SNDS nationwide claims database

29 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Acute coronary syndromes - Imaging and beyond Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Patrick Blin

University of Bordeaux, Bordeaux (France)

6 More presentations in this session

Presentation thumbnail
Added value of left atrial strain in outcome prediction after myocardial infarction. SWEDEHEART-registry based echocardiographic study.
Ms L. Sjolen (Uppsala University, SE)
Abstract Slides
Presentation thumbnail
Comparing the long-term prognosis of myocardial infarction with non-obstructive coronary arteries to myocardial infarction with obstructive coronary artery disease
Doctor G. Oliveira Campos (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Cardiopulmonary arrest and in-hospital outcomes in young patients with acute myocardial infarction: insights from the japanese nationwide registry
Mr H. Ando (Nagakute-cho, JP)
Abstract Slides
Presentation thumbnail
Where do we stand with acute myocardial infarction patients with severely reduced left ventricular ejection fraction? insights from AMIS Plus Registry
Doctor M. Cattaneo (Lugano, CH)
Abstract Slides
Presentation thumbnail
Heart rate and mortality in myocardial infarction: incremental or bimodal correlation?
Mr G. Tersalvi (Rochester, US)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes - Imaging and beyond

The Event

Event poster

ESC Congress 2022

29 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources